Analysed ALUMIS INC (ALMS:NASDAQ) News Sources
Why Alumis (ALMS) Is Down 5.8% After Positive Phase 3 Psoriasis Data And NDA Plans
04-04-2026
yahoo.com
Alumis (ALMS) Valuation Check After Positive Phase 3 Psoriasis Results For Envudeucitinib
04-04-2026
yahoo.com
Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says
30-03-2026
yahoo.com
Alumis Spotlights Phase III Psoriasis Data for Envudeucitinib, Teases NDA and Lupus Readout
30-03-2026
marketbeat.com
Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis
28-03-2026
yahoo.com
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
19-03-2026
yahoo.com
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting
18-03-2026
yahoo.com
What is the current price of ALUMIS INC (ALMS:NASDAQ)?
The current price of ALUMIS INC (ALMS:NASDAQ) is $23.06.
ALUMIS INC (ALMS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALUMIS INC (ALMS:NASDAQ) since the previous trading day is $0.12.
ALUMIS INC (ALMS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALUMIS INC (ALMS:NASDAQ) since the previous trading day is 0.5231%.
What is the most recent average sentiment score for ALUMIS INC (ALMS:NASDAQ)?
The most recent average sentiment score for ALUMIS INC (ALMS:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for ALUMIS INC (ALMS:NASDAQ)?
The most recent sentiment for ALUMIS INC (ALMS:NASDAQ) is .
SEC-8K** Filing Available For ALUMIS INC (ALMS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.